265 Do vascular markers predict cardiovascular death in primary prevention?  by Bérard, Emilie et al.
© Elsevier Masson SAS. All rights reserved.
 
84 Archives of Cardiovascular Diseases Supplements 2012) 4, 82-89
an adrenal cause is suspected although hormonal tests are recommended as
first line.
Methods: On 134 hypertensive patients uncontrolled by at least a combi-
nation therapy and with a suspicion of secondary hypertension due to adrenal
cause, an abdominal CT scan was performed in first intention. In all subjects,
an exploration of the renin-aldosteron axis in standardized conditions, a 24-
hour urinary cortisol and a WHO recommended biological analysis were also
performed afterwards.
Results: An abnormal morphology of adrenal was detected in 57.5% of
patients. Observed abnormalities were: bilateral hyperplasia (30.6%), unilat-
eral adenoma (15.7%), unilateral hyperplasia (6.7%) and bilateral adenoma
(4.5%). Abnormal adrenal hormonal tests were recorded in 16.4% of patients,
with a primary aldosteronism (A/R corrected> 23) found in 10.4% and
increased urinary cortisol in 6%. Treatment implementation was decided upon
morphologic and hormonal results. At 6 months of follow-up, a controlled
blood pressure was observed in 73.1% of subjects, spironolactone had been
prescribed in 41.8% of subjects and adrenal surgery performed in 3.7% of
patients. If hormonal tests had only been performed, a retrospective analysis
showed that treatment with spironolactone would have been prescribed only in
12.6% of subjects and an adrenal surgery been proposed only in 2.9% of
patients.
Conclusion: In our population of patients with a resistant hypertension and
adrenal disease suspicion, abdominal CT scan as a first line investigation leads
directly to the conclusion of an adrenal aetiology in 45.5% of patients. In con-
trast, a specific treatment would have been undertaken only in 15.5% of
patients if screened by hormonal examinations only. This study suggests that
in subjects with uncontrolled hypertension and suspected to have an adrenal
cause, abdominal CT scan is an efficient first line investigation.
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Purpose: The purpose of the study was to determine the prognostic signif-
icance of vascular markers in apparently healthy subjects.
Methods: Analyses were based on the Third South-Western French
MONICA Survey (1995-1996) carried out in participants aged 35-64. Vital
status, date and cause of death were obtained 14 years after inclusion. Subjects
with a personal history of Atherosclerotic Cardiovascular Disease or with a
personal history of Severe Chronic Disease were excluded. Pulse Wave
Velocity (PWV), Pulse Pressure (PP), presence of carotid or femoral athero-
sclerotic plaques, and carotid Intima-Media Thickness (IMT) were assessed.
Identification of the determinants of cardiovascular mortality was based on a
multivariable survival analysis.
Results: There were 1144 participants (587 (51%) men). Over the 14-year
study period, there were 63 deaths, 21% due to a cardiovascular cause (Isch-
emic Heart Disease, Atherosclerotic Cerebrovascular Disease or Atheroscle-
rosis). The median 10-year risk of coronary event according to the
Framingham Risk Score (FRS) was 6.4%. PWV, PP, and carotid or femoral
atherosclerotic plaques were all significant and independent determinants of
cardiovascular mortality, whereas carotid IMT was no longer associated with
cardiovascular mortality after adjustment for FRS. The addition of PWV, PP
or atherosclerotic plaques to FRS in a prediction model resulted in an
improvement of the discriminatory value of the model as shown by the C-sta-
tistic which was 0.76 [95% CI: 0.61-0.90] for FRS alone, 0.80 [95% CI: 0.64-
0.95] for FRS and PWV, 0.80 [95% CI: 0.65-0.95] for FRS and PP, and 0.77
[95% CI: 0.60-0.94] for FRS and plaques. Using PWV, PP and plaques in the
prediction model led to a Net Reclassification Improvement of 22, 19 and
25%, respectively.
Conclusion: Vascular markers are independent determinants of cardiovas-
cular mortality risk in apparently healthy subjects in primary cardiovascular
prevention and improve classification of subjects.
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Purpose: Our objective was to assess the long term prognosis value of
ABI in a contemporary large cohort of pts with known CAD.
Methods. Among 834 consecutive male pts hospitalized in 2001-2004 for
coronary artery disease, ABI was measured in 776 pts. ABI –0.9 was consid-
ered as abnormal. ABI –0.9 and > 0.6 was considered as low and ABI0.6 as
very low. The median follow-up was 7.17 years. Total mortality was predicted
with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic,
155 pts (19.8%) were smokers, and median heart rate was 61 bpm [Interqua-
tile range (IQR)] [57-70]. Mean left ventricular ejection fraction was 0.53
(0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-blocker, 66% on
statin therapy and 54.8% on ACE inhibitors or ARB.
The sample comprised 518 pts (67%) with normal ABI and 258 (33%)
with abnormal ABI (215 (83.3%) pts had a low and 43 (16.7%) a very low
ABI). The cumulative seven-year total mortality rate was 17.6%. In the
normal ABI group, mortality rate was 13.9%, whereas it was 21.4% in the low
and 44.2% in the very low ABI group (p<0.001).
After multivariate adjustment for age, diabetes, tobacco consumption (none;
40 pack-years; >40 pack-years), heart rate, duration of CAD, left ventricular
ejection fraction (>0.5; 0.5 and > 0.35; 0.35), history of chronic obstructive
pulmonary disease or stroke, statin therapy and coronary revascularization,
hazard ratio (HR) for all-cause death was 1.36 (95% CI [0.92; 2.03] p=0.12) for
low ABI and 2.48 (95% CI [1.41; 4.36] p=0.002) for very low ABI compared
to pts with normal ABI. Including ABI in the prediction model significantly
increased the C-statistic (from 0.80 to 0.82, p=0.03).
Conclusion: ABI is a strong and independent long term predictor factor of
all-cause death in CAD. To better identify pts at very high risk, systematic
ABI assessment should be promoted.
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Background: Angina with angiographically normal coronary arteries
(NCA) still has controversial pathophysiological mechanisms. Experimental
studies have shown that coronary blood flow varies with aortic (Ao) stiffness,
but clinical data are poor.
Objective: To assess Ao vascular function by different echocardiographic
techniques in patients (pts) with angina and NCA vs asymptomatic pts.
Methods: Study group consisted of 15 pts with angina and NCA (mean
age 60,9±5,3 yrs) and 15 age and gender- matched control subjects (normal
and hypertensives pts) .
Ascending Ao diameters – derived stiffness indices were: Ao strain, Ao
distensibility (Ao dis), Ao stiffness index (Ao SI). Ao function was evaluated
also by measuring tissue Doppler (TdI) systolic (SW), early and late dia-
stolic(EW, AW) velocities of the anterior Ao wall. Total afterload was defined
by the effective arterial elastance (Ea=0.9XSBP/SV, SV=stroke volume). Sys-
temic vascular resistance index (SVRI)= mean arterial pressure/cardiac index.
Total arterial compliance (Ca)=SV/pulse pressure.
